会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Diagnostic agent for diabetes
    • 诊断糖尿病
    • EP0913161A2
    • 1999-05-06
    • EP98308523.4
    • 1998-10-19
    • Tokyo Gas Co., Ltd.
    • Kohno, TadashiHosoi, IsaburoOhshima, JunkoIto, AsukaShibata, Kunihiko
    • A61K51/04
    • A61K51/1206A61K49/1815
    • The present invention relates to a diagnostic agent for diabetes, comprising a compound labelled with 13 C at least at one specific position selected from the group consisting of the following (a) to (g):

      (a) galactose, fructose or xylose labelled with 13 C at least at one specific position, or a starch composed of glucose units labelled with 13 C at least at one specific position;
      (b) an amino acid labelled with 13 C at least at one specific position;
      (c) lactic acid or citric acid labelled with 13 C at least at one specific position;
      (d) a fatty acid labelled with 13 C at least at one specific position;
      (e) a glyceride labelled with 13 C at least at one specific position;
      (f) glycerol labelled with 13 C at least at one specific position; and
      (g) aminopyrin of which the dimethylamino group at position 4 is labelled with 13 C, phenacetin of which the ethoxy group is labelled with 13 C at position 1, or methacetin of which the methoxy group is labelled with 13 C.
    • 本发明涉及糖尿病诊断剂,其包含至少在选自以下(a)至(g)中的至少一个特定位置标记的化合物:(a)半乳糖,果糖或木糖 至少在一个特定位置标记为13 C,或由至少在一个特定位置由13 C标记的葡萄糖单元组成的淀粉; (b)至少在一个特定位置用13 C标记的氨基酸; (c)至少在一个特定位置用13 C标记的乳酸或柠檬酸; (d)至少在一个特定位置用13 C标记的脂肪酸; (e)至少在一个特定位置用13 C标记的甘油酯; (f)至少在一个特定位置用13 C标记的甘油; 和(g)其中位置4的二甲基氨基被标记为13 C的氨基吡啶,其中乙氧基在13位被标记为13 C的美沙西丁,其中甲氧基被标记为<13 >℃。
    • 4. 发明公开
    • Diagnostic agent for liver function
    • 肝功能的诊断剂
    • EP1304125A2
    • 2003-04-23
    • EP02029007.8
    • 1998-10-05
    • Tokyo Gas Co., Ltd.
    • Kohno, TadashiHosoi, IsaburoOshima, JunkoIto, AsukaShibata, Kunihiko
    • A61K51/12A61K51/04
    • A61K51/1206
    • The present invention relates to a diagnostic agent for liver function, comprising a compound labelled with 13 C at least at one specific position selected from the group consisting of the following (a) to (f):

      (a) galactose, glucose or xylose labelled with 13 C at least at one specific position or a starch composed of glucose units labelled with 13 C at least at one specific position;
      (b) a polar amino acid, heterocyclic amino acid, isoleucine or valine labelled with 13 C at least at one specific position;
      (c) a carboxylic acid constituting the glycolytic pathway or the citric acid cycle, labelled with 13 C at least at one specific position;
      (d) a fatty acid labelled with 13 C at least at one specific position;
      (e) a glyceride labelled with 13 C at least at one specific position; and
      (f) glycerol labelled with 13 C at least at one specific position.
      According to the present invention, a diagnostic agent for liver function which imposes less physical burden on a subject, can give accurate test result immediately, and can be used safely without side effects is provided. The diagnostic agent of the invention is useful for evaluating the liver function of a subject at the time when the test is carried out.
    • 本发明涉及用于肝功能的诊断剂,其包含至少在选自下列(a)至(f)的至少一个特定位置上用13C标记的化合物:(a)用(a)标记的半乳糖,葡萄糖或木糖 13C至少在一个特定位置处或由至少在一个特定位置处用13C标记的葡萄糖单位组成的淀粉; (b)至少在一个特定位置用13C标记的极性氨基酸,杂环氨基酸,异亮氨酸或缬氨酸; (c)至少在一个特定位置用13C标记的构成糖酵解途径或柠檬酸循环的羧酸; (d)至少在一个特定位置用13C标记的脂肪酸; (e)至少在一个特定位置用13C标记的甘油酯; 和(f)至少在一个特定位置用13C标记的甘油。 根据本发明,提供一种肝脏功能诊断剂,其对受试者施加较少的身体负担,可以立即给出准确的测试结果,并且可以安全地使用而没有副作用。 本发明的诊断剂可用于在进行测试时评估受试者的肝功能。
    • 5. 发明公开
    • Diagnostic agents for pancreatic exocrine function
    • 使用13C或14C标记的氨基酸或肽作为胰腺外分泌功能的诊断剂
    • EP0966975A2
    • 1999-12-29
    • EP99304388.4
    • 1999-06-04
    • Tokyo Gas Co., Ltd.
    • Kohno, TadashiHosoi, IsaburoOhshima, JunkoShibata, KunihikoIto, Asuka
    • A61K51/08
    • A61K51/1206A61K49/1815
    • A diagnostic agent for pancreatic exocrine function comprising an amino acid or a peptide containing at least one 13 C or 14 C atom, or a pharmaceutically acceptable salt thereof other than Bz-Tyr- 13 C-PABA is provided. A 13 C- or 14 C-labeled compound represented by the following formula (II):

              X 2 -R 2 -Y 2 -Z 1      (II)



      or a salt thereof,
      wherein X 2 is a hydrogen atom or a protecting group,
      R 2 is a peptide of 2 to 5 amino acids, an amino acid or a single bond, Y 2 is an amino acid,
      Z 1 is an amino acid optionally having a protecting group, and
      at least one of the amino acids in R 2 ,Y 2 and Z 1 , or at least one of the protecting groups in X 2 and Z 1 when the protecting groups contain a carbon atom, is 13 C or 14 C-labeled.
    • 对于胰腺外分泌功能,其包括氨基酸或含有至少一个<13> C或<14>的C原子,或它们的比的Bz-Tyr <13>其他药学上可接受的盐的肽的诊断剂C-PABA设置。 由下式表示的<13> C-或<14> C标记的化合物(II):X2-R2-Y2-Z1或其盐,worin X2是氢原子或保护基团,R 2是一个肽 中的氨基酸或一个单键2至5个氨基酸,Y2是一种氨基酸,Z1是氨基酸任选地具有保护基团,和在R 2,Y2and Z1的氨基酸中的至少一个,或至少一个 在X2和Z1中的保护基团当保护基团含有的碳原子的,为<13> C或<14> C标记。